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There is an increasing body of evidence, including that from prospective population studies and
epidemiological observational studies, suggesting a strong inverse relationship between
increased consumption of wholegrain foods and reduced risk of CVD. This evidence has
translated into specific dietary recommendations in the USA to consume at least three servings
of whole grain per d, and has informed the development of specific health claims for
wholegrain foods both in the USA and in Europe. Wholegrain foods are rich sources of many
nutrients and phytochemicals, including complex carbohydrates, dietary fibre, minerals,
vitamins, antioxidants and phyto-oestrogens such as lignans. Many of these components are
lost from the grain during processing and although some may be replaced (such as in the
mandatory fortification of white flour), this practice ignores the possible synergistic effects of
the ‘natural’ constituents. The notion that wholegrain foods are simply a source of dietary fibre
has been dispelled, although the additional components that contribute to the health benefits
have not been clearly identified. In addition, the mechanisms by which wholegrain foods may
have their effect are poorly understood. At present there are few strictly-controlled intervention
studies that have confirmed a beneficial effect of increased consumption of wholegrain foods,
demonstrated the level of consumption required to elicit a beneficial effect or provided
evidence of modes of action. Although wholegrain foods are considered amongst the healthiest
food choices available, their consumption falls well below current recommendations, which
have been based mainly on epidemiological evidence. Well-controlled intervention studies are
needed to provide more detailed mechanistic evidence to support the health claims and findings
which can be used to develop effective public health strategies to promote whole-grain
consumption.
Whole grain: CVD: Antioxidants: Disease risk
Whole grains
Whole grains as foods in the human diet are not a new
invention. Evidence of their consumption can be found in
ancient petroglyphs and remains have been found in
preserved coprolites. Stable-isotope signatures in hair from
5200-year-old Ice Man are consistent with the consump-
tion of vegetarian diets based on C3 plants (Macko et al.
1999). Until relatively recent history grains were crushed
and ‘milled’ to produce coarse flours and were essentially
consumed as ‘whole grains’, with a poor and incomplete
separation of the bran and germ from the endosperm.
With the development of the roller mill separation became
more efficient, and since that time consumption of refined
grains has increased dramatically, especially in Western
industrialised countries, almost to the exclusion of whole
grains. Consumption of whole grains has increased slightly
since the 1970s when the ‘fibre hypothesis’ promoted the
potential health benefits of fibre-rich foods, including those
derived from whole cereal grains (Trowell, 1979).
The cereal grains consumed by man are the seeds of
the Gramineae family of grasses. The most commonly
consumed are wheat, rice and maize, although barley, oats,
rye, millet and sorghum are more common in some
countries than in others depending on climate and cultural
differences (Southgate, 2000). Whole grains are composed
of three principal parts, the bran, the germ and the endo-
sperm; the relative amounts of these constituents differ
from one species to another. For example, brown rice
has a very low bran content (30 mg/g) compared with
maize (approximately 60 mg/g) and wheat (£160 mg/g).
Similarly, the soluble fibre content of oats, barley and rye
is much higher than that found in wheat. Bran and germ
contain many nutrients, and non-nutrient inorganic and
organic components, many of which are lost during the
refining process; the extent of the loss depends on the
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extent of extraction (Smith et al. 2003). Although some
of these constituents can be replaced into the refined
flour through mandatory fortification policies, there is a
consensus view (Pereira et al. 2001; Slavin, 2003) that
suggests that consumption of the fortified product is not the
same as consumption of the original grain product with its
more complex structure. In the majority of modern milling
practices the individual components of the grain are
separated but then re-constituted to re-form the wholegrain
(wholemeal) flour. The American Association of Cereal
Chemists have sought to produce a definition of whole
grain that will be of benefit to consumers and food manu-
facturers. The definition, which was approved and adopted
in 1999, is: ‘Whole grains shall consist of the intact,
ground, cracked or flaked caryopsis, whose principal
anatomical components – the starchy endosperm, germ and
bran – are present in the same relative proportions as they
exist in the intact caryopsis’ (American Association of
Cereal Chemists, 2005).
It is important to note that wholegrain foods are not
‘unprocessed’; the average consumer does not eat intact
whole grains except in small quantities in some mueslis or
when added as texture in some breads. Grains are altered
mostly during milling in order to improve flavour, colour,
palatability, appearance and cooking characteristics as
well as to provide shelf-stable products. It is unusual to
consume wholegrain flours in which the constituent parts
have not been separated during the milling process, with
the exception generally of stoneground or specialist flours.
In addition, flours themselves are subjected to considerable
shear forces during milling. This, together with the frac-
tionation and re-constitution procedures will, inevitably,
result in changes to the gross morphology of the product
and most likely the chemical composition.
Definition of wholegrain foods and health claims
The US Food and Drug Administration was the first
authority to allow a health claim based on wholegrain
foods, which was approved by Congress in 1999 under
the Food and Drug Administration Modernisation Act
(Wiemer, 2002). The health claim was approved as an
‘authoritative statement’ following an industry-led sub-
mission by General Mills (Minneapolis, MN, USA) and
reads as follows: ‘Diets rich in wholegrain foods and other
plant foods and low in total fat, saturated fat, and choles-
terol may reduce the risk of heart disease and some
cancers’ (Food and Drug Administration, 1999). A second,
modified, health claim was approved in 2003 (Food and
Drug Administration, 2003). The difference between the
two statements is that because fat per se is not associated
with increased risk of heart disease (it is the saturated
fat and cholesterol that are the problem) foods bearing
the second health claim do not need to meet the nutrient
content claim of a ‘low-fat’ food, but can contain moderate
levels of fat. The Food and Drug Administration (1999)
have defined a wholegrain food as a product containing
>51% whole grain by weight per reference amount
customarily consumed per d. In order to use the health
claim, and consider the food as a ‘wholegrain food’, the
whole grain ingredients must be present in sufficient
quantity to characterise the food (hence the dominant or
first ingredient in the ingredient list must be a whole
grain), and the food must provide a minimum of 16 g
whole grain/reference amount customarily consumed
(Richardson, 2003). Europe has followed the US lead, first
with the Joint Health Claims Initiative concluding that
‘people with a healthy heart tend to eat more wholegrain
foods as part of a healthy lifestyle’. The process leading to
this statement, and the evidence considered, has been
recently reviewed by Richardson (2003). The Swedish
Nutrition Foundation (2003) issued the stringent, if rather
long, statement ‘A healthy lifestyle and a well balanced
diet rich in wholegrain products reduces the risk for
(coronary) heart disease. The product X is rich in whole-
grains (contains Y% of wholegrain)’. Thus, although there
is considerable evidence that diets rich in wholegrain foods
are associated with reduced risk of some cancers and type
2 diabetes, the focus driven through the food industry has
been on the association with reduced CVD.
Whole grains and CVD risk, epidemiological and
experimental evidence of benefit
CVD encompass a range of pathologies, including disease
of the arteries supplying blood to the muscles of the
heart (CHD or IHD), the brain (cerebrovascular disease or
stroke) and the extremities, especially the legs (peripheral
vascular disease, e.g. deep-vein thrombosis). The disease
involves the processes of atherosclerosis (lesions of the
arteries caused by fat deposition), arteriosclerosis (caused
by Ca deposition) and thrombosis (blood clotting).
Collectively CVD are the most common causes of death in
Western countries, accounting for >40% of all deaths.
CHD is the single largest cause of death in the UK
(British Heart Foundation, 2005) and US (American Heart
Association, 2005).
Recognising the protective association between the
consumption of wholegrain foods and CVD is not new.
Trowell (1972) first proposed that wholegrain foods are
protective against IHD, but this proposal has been
re-interpreted as a ‘fibre’ hypothesis rather than a ‘high-
fibre food’ hypothesis (Anderson et al. 2000; Anderson,
2004), with the consequence that ‘fibre’ has become the
focus of public health recommendations rather than placing
the emphasis on whole foods. In one of only a small
number of studies from the UK Morris et al. (1977) have
reported an 80% reduction in heart attacks in men when
those with the highest cereal-fibre intake compared with
those with the lowest intakes. Subsequently, a number of
large epidemiological and controlled studies, mainly based
in the USA, have reported negative associations between
whole-grain intake and risk for CHD. These studies
have been reviewed by Anderson et al. (2000), and their
analysis has been recently updated by Anderson (2003).
The results of these meta-analyses confirm the suggestion
that whole grains are more effective in reducing risk of
CVD than other foods commonly eaten such as fruit or
vegetables, and that this effect is independent of cereal
fibre. Indeed, for cereal fibre alone Anderson (2003) has
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demonstrated that there is no protective effect against
CVD, suggesting that the bran and outer germ are impor-
tant factors in the protective mechanisms associated with
whole grains. A brief summary of the important larger
studies is shown in Table 1. In reporting the effects of
wholegrain foods on disease risk it is important to note
that whole-grain intake can be a marker of a generally
healthier lifestyle, including increased physical activity
and lower smoking rates, which are themselves key factors
in determining heart disease risk (see Anderson et al.
2000). Thus, the data shown in Table 1 show the results of
full-models adjustments. In all cases the full-models
adjustments reduce the significance of the whole-grain
effect compared with unadjusted data, but still support the
overall observation of reduced risk with increasing whole-
grain intake.
In addition to the larger population-based studies there
are some smaller studies showing positive effects of
increased whole-grain intake on measures of cardio-
vascular function. For example, Erkkila¨ et al. (2005) in a
study with 229 post-menopausal women with established
coronary artery disease have shown that those women
consuming more than the median intake of six servings of
whole grains per week have a lower decline in minimum
coronary artery diameter and show a trend towards lower
progression in percent stenosis over a 3-year follow-up.
In a smaller study with twenty-one non-hypertensive
men Hallfrisch et al. (2003) have reported that consuming
high-fibre diets based on insoluble fibre (brown rice and
wheat) and/or soluble fibre (barley) results in lowering of
systolic, diastolic and mean arterial pressure compared
with the Step 1 American Heart Association diet.
Table 1. Effects of whole-grain consumption on CVD risk*
Risk factor or end point Study and no. of subjects Outcome Reference
Death rates from CVD Iowa Women’s Health Study (baseline
data from 1984, follow-up to 1995)
34 333 women
HR of all CVD across quintiles of
whole-grain intake was 0.82
(95% CI 0.66, 1.01; P = 0.02)
Jacobs et al. (1999)
HR for deaths from CHD across quintiles
of whole-grain intake was 0.82
(95% CI 0.63, 1.06; P = 0.03)
HR for deaths from stroke and other
CVD were not significantly different
across quintiles of whole-grain intake
Incidence and deaths
from IHD
California Seventh-day Adventists
(baseline data from 1976, 6-year
follow-up) 13 857 men, 20 341 women
RR of fatal IHD was lower (0.89;
P<0.005) and non-fatal IHD was
lower (0.56; P<0.01) in those who
preferred wholegrain bread compared
with those who preferred white bread
Fraser (1999)
Incidence and deaths
from CHD
Nurses’ Health study (baseline data from
1984, average 10-year follow-up)
75 521 women
RR for cases of CHD across quintiles
of whole-grain intake was 0.47 (95%
CI 0.27, 0.79; P = 0.006) for never
smokers, and was 0.79 (95% CI 0.62,
1.01; P = 0.07) for the full cohort
Incidence of ischaemic
stroke
Nurses’ Health study (baseline data from
1984, average 12-year follow-up)
75 521 women
RR of incident IHD across quintiles of
whole-grain intake was 0.69 (95% CI
0.50, 0.98; P = 0.03)
Liu et al. (2000b)
Death rates from CHD
and CVD
Bread eaters in Norwegian County Study
(data from 1977 to 1994) 16 933 men,
16 915 women
HR of death from CHD across quintiles
of wholegrain bread consumption was
0.75 (95% CI 0.65, 0.88; P = 0.006)
Jacobs et al. (2001)
HR of CVD across quintiles of
wholegrain bread consumption was
0.77 (95% CI 0.60, 0.98; P = 0.016)
Incidence of coronary
artery and ischaemic
stroke
Atherosclerosis Risk in Communities
cohort (baseline data in 1987–9,
11-year follow-up) 11 940 subjects
HR of incident coronary artery disease
across quintiles of whole-grain
intake was 0.72 (95% CI 0.53,
0.97; P = 0.05)
Steffen et al. (2003)
HR of incident ischaemic stroke across
quintiles of whole-grain intake was
0.75 (95% CI 0.46, 1.22; P = 0.15)
Non-fatal myocardial
infarction and fatal
CHD
Health Professionals Follow-up study
(data from 1986 to 2000) 42 850 men
HR of CHD between highest and lowest
quintile of whole-grain intake was 0.82
(95% CI 0.70, 0.96; P = 0.01)
Jensen et al. (2004)
HR, hazard ratio; RR, relative risk.
*Unless otherwise stated HR or RR have been reported using any fully-adjusted model including all adjustments for demographic, dietary and non-dietary factors
and the subject numbers shown are the numbers in the adjusted model.
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Mechanisms of action
Very few studies have been undertaken on the physio-
logical effects of consuming diets high in wholegrain
foods, and thus the mechanisms of action of these products
remain somewhat speculative. There are, of course,
additional complications associated with unravelling the
effects of whole foods compared with single nutrients or
pharmacological agents. As discussed previously, whole
grains are derived from a range of different species, they
are consumed in a variety of different forms and thus they
contribute different patterns of nutrients and bio-active
compounds to the diet. Thus, it is highly likely that no
single component or ‘mechanism’ will account for their
beneficial effects. Rather, it is probably the combination
of a range of different synergistic processes that are modu-
lated or improved and result in an overall health benefit.
Antioxidant effects of wholegrain foods
Antioxidants include a wide range of compounds that delay
or prevent pro-oxidant-initiated oxidation of substrates and
are present in a variety of forms in foodstuffs (Halliwell
et al. 1995). Thus, antioxidants include many molecules
such as minerals, vitamins, proteins, carbohydrates and
polyphenolics that are capable of donating an electron(s) to
a pro-oxidant. Antioxidants in foods may exert their effects
in the gut lumen or, once absorbed, in cells and tissues
within the body. These ‘exogenous’ sources of antioxidants
contribute to the body’s overall antioxidant potential,
which also includes ‘endogenous’ antioxidant molecules
and enzymes synthesised within cells in response to
oxidative stress. The balance between endogenous and
exogenous antioxidants in moderating oxidative stress is a
matter of some conjecture, since methods for measuring
antioxidant status are very broad in their specificity and
cannot distinguish between the different molecular species
(Cao & Prior, 1998). In general, however, avoidance of
oxidative stress is important in protecting the body against
the consequences of oxidative damage to DNA, proteins
and lipids (Sies et al. 2005). Unsaturated fatty acids
incorporated into LDL are very prone to oxidative damage
and oxidised LDL are strongly atherogenic. Improvements
in antioxidant status and concomitant reduction in LDL
oxidation products are therefore important in reducing
cardiovascular risk.
Whole grains contain many water-soluble and fat-
soluble antioxidants, including trace minerals, vitamins,
phenolic acids, lignans, phytic acid, tocopherols, toco-
trienols and phyto-oestrogens. These antioxidant com-
pounds have been extracted and measured by several
methods (Ka¨hkonen et al. 1999; Zielinski & Kozlowska,
2000; Adom & Liu, 2002; Halvorsen et al. 2002). The
majority of the procedures described in these studies rely
on the use of solvents to produce an antioxidant extract
that clearly demonstrates a range of antioxidant contents
for the different products. However, these extraction
procedures are essentially ‘non-physiological’ and do not
necessarily reflect the available antioxidant that can be
released from the food matrix during passage through the
gastrointestinal tract. An in vitro procedure has recently
been used to mimic the different phases of digestion
through the intestines, using sequential acid, alkali and
enzymic steps to provide a more physiological measure of
available antioxidant (Nagah & Seal, 2005). The results
demonstrate that antioxidant release is dependent on
the incubation conditions and suggest that as digestion
progresses antioxidants can be released from within the
food matrix. The apparent antioxidant content of the
wholegrain foods is higher than that of refined-grain
alternatives, but much lower than that measured in fruits
and vegetables (Fig. 1). Wholegrain foods therefore have
potential as sources of antioxidants, but the extent to which
their consumption can affect antioxidant status in animals
or man is not clear.
The impact of consuming wholegrain products on anti-
oxidant status has been measured using both animals and
human subjects. For laboratory rats fed diets containing
500 g wholemeal wheat, wholemeal rye or brown-rice
flours/kg for 21 d the plasma antioxidant capacity is not
different from that of rats fed a control diet containing
500 g maize starch/kg (Nagah, 2005). The antioxidant
content of urine is highest for rats fed wholemeal rye,
although the antioxidant content of faeces is similar for
rats fed all three wholegrain diets (Fig. 2), albeit higher
than that for the animals fed maize starch. The CHEW-IT
study (Jones et al. 2004a,b) was a whole-grain intervention
study with human subjects in which participants were
asked to consume three 23 g servings of wholegrain food
per d for 8 weeks and then increase their wholegrain food
consumption to six 23 g servings per d for a further 8
weeks. Fasting blood samples and 24 h urine collections
were taken at baseline, 8 and 16 weeks. The antioxidant
capacity of plasma shows no difference during the inter-
vention (Fig. 3(a, b)). However, the antioxidant output in
urine increases progressively with increasing wholegrain
intakes (Fig. 3(c, d)). The lack of response in plasma
antioxidant measures is disappointing as compliance
0 50 100 150 200
Apparent antioxidant release (mM–FIE/g)
Bulgur
Wholewheat spaghetti
Wholemeal bread
Brown rice
Oat porridge
Sun dried tomatoes
Apple
Fig. 1. Apparent antioxidant content (expressed as Fe2+
equivalents (FIE); mM) in some wholegrain foods in comparison
with fruit determined using the ferric-reducing activity power assay.
(Data from Nagah & Seal, 2005.)
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with the intervention was good (AR Jones, S Kuznesof,
DP Richardson and CJ Seal, unpublished results), perhaps
suggesting that fasting blood samples are not good
indicators of antioxidant status in these healthy individuals.
In the rat model plasma samples also show no difference
despite large intakes of very different wholegrain products.
Interestingly, however, urinary antioxidant output in
both studies appears to respond to changes in the diet.
Increased urinary output may be indicative of water-
soluble components that have been absorbed through
the gut and then excreted in urine. Transient changes in
the antioxidant capacity of plasma have been reported
following tea consumption (Langley-Evans, 2000; Leenen
et al. 2000), with maximum values reached approximately
1 h after drinking the tea. In the latter study it was found
that antioxidant status measured using the ferric reducing
ability of plasma assay continues to rise with hourly tea
consumption, but the time taken to return to baseline
values was not reported. Consuming meals with whole-
grain foods containing higher levels of antioxidants may
also result in postprandial fluctuations in apparent anti-
oxidant status and this response would be an area of
interest for future research. In addition, the relative insen-
sitivity and lack of specificity of the analytical methods
commonly used (the ferric-reducing activity power assay
(Benzie & Strain, 1996) and the Trolox equivalent anti-
oxidant capacity method (Re et al. 1999)) may also mask
beneficial effects, and further analysis of specific anti-
oxidant compounds present in wholegrain foods and their
absence or presence in plasma will be required in order to
determine whether they can make a major contribution to
antioxidant status.
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Fig. 2. Antioxidant capacity (expressed as Fe2+ equivalents (FIE);
mM) of plasma (a), urine (b) and faeces (c) in rats fed semi-purified
diets containing 500 g maize starch (control; K), brown-rice flour
(BR; ///), wholemeal rye flour (WR; \\\) or wholemeal wheat flour
(WW; )/kg, determined using the ferric-reducing activity power
assay. Urine and faecal samples were collected during a 7 d
balance period at the end of the 21 d feeding period. Plasma
samples were separated from whole blood taken at the end of the
21 d feeding period. Values are means with their standard errors
represented by vertical bars for five rats per group. (From Nagah,
2005.)
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Fig. 3. Antioxidant capacity of plasma (a, b) and 24 h urine (c, d)
samples from human subjects consuming three 23 g servings of
wholegrain food per d for 8 weeks followed by six 23 g servings of
wholegrain food per d for an additional 8 weeks, determined using
the ferric-reducing activity power assay (expressed as Fe2+
equivalents (FIE); b, d) and Trolox equivalent antioxidant capacity
method (expressed as Trolox equivalents (TE); a, c). (K), Baseline;
(////), 8 weeks; ( ), 16 weeks. Values are means for thirty-two sub-
jects. (Data from A Jones and CJ Seal, unpublished results.)
28 C. J. Seal
Mammalian lignans and whole grains
The major sources of dietary lignans in human nutrition are
the cereals, although fruits and berries also contribute to
intake. However, soyabean and flaxseed contain much
higher concentrations of lignans than cereals, so intakes
can vary greatly between populations for whom these
foods are more common in the diet. Within cereals there is
also considerable variation in lignan precursors, and rye is
particularly high in lignans; thus, populations such as the
Finns who consume large quantities of rye products are
also likely to have higher intakes.
Lignans are consumed as precursor molecules, pre-
dominantly matairesinol and secoisolariciresinol, that are
converted to the active mammalian lignans enterolactone
and enterodiol by the colonic microflora. With the devel-
opment of analytical methods for the determination of
dietary lignans, the number of precursors identified
has increased (Nurmi & Adlercreutz, 1999). However,
the contribution of these precursors to enterolactone and
enterodiol concentrations in plasma remains uncertain.
Lignans are potent antioxidant molecules and have been
shown to be protective against hormone-related cancers
(Pietinen et al. 2001; Pietinen & Kilkkinen, 2002;
Hallmans et al. 2003; Qu et al. 2005). In vitro the lignans
do not bind to the oestrogen receptor (Saarinen et al.
2000), but enterolactone inhibits human oestrogen
synthetase by binding to the active site of the P450 enzyme
(Adlercreutz et al. 1993).
Population data on lignan intakes are largely unreliable
since the lignan content of many foodstuffs is not known,
especially for the newly-identified precursor molecules.
Recently, however, analyses based on new food-
composition data have become available (for example, see
Milder et al. 2005) and they show that early estimates
considerably underestimated lignan intake. Also, plasma
enterolactone and enterodiol concentrations are strongly
correlated with intake (Kilkkinen et al. 2001, 2003; Horner
et al. 2002; Johnsen et al. 2004). Furthermore, feeding of
wholegrain rye, wheat and brown rice to rats results in
higher plasma concentrations and urinary excretion of
enterolactone and enterodiol than feeding maize starch
(Nagah et al. 2004; Nagah, 2005), as does feeding whole-
grain rye to pigs (Bach Knudsen et al. 2003). In both
animals and human subjects, however, there is consider-
able intra-individual variability in plasma concentrations,
which may be related to the extent of conversion of plant
lignan precursors to mammalian lignans, which is strongly
dependent on the activity of the gut microflora (Kilkkinen
et al. 2001; Grace et al. 2003; Niemeyer et al. 2003),
and the ability to absorb the metabolites (Bowey et al.
2003). The metabolic consequences of elevated plasma
enterolactone and enterodiol concentrations have not been
elucidated, and more evidence from human studies is
required to confirm whether these molecules are involved
in reducing CVD risk and to elucidate their mechanisms of
action. It is possible that the lignans may possess similar
cardioprotective effects to those reported for other poly-
phenolic compounds, including reducing LDL-cholesterol
oxidation, changes in cholesterol synthesis and re-cycling,
and changes in the metabolism of triacylglycerols (Zern &
Fernandez, 2005), although as yet there is limited evidence
to support these hypotheses. Men from the Kuopio
Ischaemic Heart Disease Risk Factor Study in the highest
quartile of serum enterolactone concentrations were found
to have a 65% lower risk of acute coronary events than
men from the lowest quartile (Vanharanta et al. 1999).
However, serum total cholesterol and LDL-cholesterol
concentrations were not found to be different between
the quartiles. In a study of post-menopausal women
Kreijkamp-Kaspers et al. (2005) have shown a trend for
lower total cholesterol and LDL-cholesterol concentrations
across tertiles of lignan intake that again was not
significant. In a recent analysis of a subgroup of subjects
from the Health Professionals Follow-up Study van der
Schouw et al. (2005) have reported that concentrations of
LDL-cholesterol and apoB tend to increase across quartiles
of increasing lignan intake (for LDL-cholesterol: from
quartile 4 to quartile 1, 9%; P = 0.01 for trend; for apoB:
from quartile 4 to quartile 1, 9%; P = 0.02 for trend).
However, fasting insulin and C-peptide tend to decrease
across quartiles of lignan intake (for insulin: from quartile
4 to quartile 1, -11%; P = 0.02 for trend; for C-peptide:
from quartile 4 to quartile 1, - 25%; P = 0.01 for trend).
Both these studies have limitations in the quantification
of lignan intake, which was calculated from dietary data
collected from a food-frequency questionnaire not specifi-
cally designed for this purpose, and no measures of lignan
‘status’ were determined.
Changes in insulin resistance
Insulin resistance and hyperinsulinaemia are associated
with increased risk of CVD (Shinozaki et al. 1996; Katz
et al. 1999; Golden et al. 2002; Uwaifo & Ratner, 2003).
However, the impact of the source and type of carbo-
hydrate on the development of insulin resistance is incon-
clusive (Daly et al. 1997). In a study using laboratory rats
Byrnes et al. (1995) have shown that feeding rapidly-
digested starch with a high amylopectin content results in
increased plasma insulin concentrations following an
intravenous glucose challenge. The mechanisms involved
in this increase in insulin resistance have not been eluci-
dated, and it is uncertain whether these results can be
extrapolated to man. In acute studies starches that are
rapidly digested (high glycaemic index; GI) result in
higher postprandial glucose and insulin responses com-
pared with starches that are more slowly digested (lower
GI; Seal et al. 2003; Ells et al. 2005). Recurrent post-
prandial exposure to high plasma glucose and high plasma
insulin as a result of habitual consumption of refined
high-GI carbohydrate foods may contribute to the
development of insulin resistance. Indeed, changing from
high-GI foods to low-GI foods has been shown to result in
improved insulin sensitivity (for example, see Frost et al.
1998). Wholegrain foods with intact germ and bran may
have lower GI values than foods containing refined carbo-
hydrate (Foster-Powell & Brand-Miller, 1995). However,
grinding or milling cereals during processing removes the
bran layer and reduces particle size, allowing more rapid
digestion by digestive enzymes, and thus wholegrain foods
do not necessarily have a lower GI. It would be expected,
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however, that diets rich in wholegrain foods may result in
improved insulin sensitivity, and there is some evidence
to support this hypothesis from epidemiological studies
that have demonstrated associations between lower fasting
insulin concentrations and glycaemic response and
increased consumption of whole grains (Pereira et al.
1998; Fung et al. 2002). In one study in which insulin
sensitivity was measured by intravenous glucose-tolerance
test Liese et al. (2003) have shown an increase in insulin
sensitivity with increased whole-grain consumption.
This association is attenuated, but not removed, when
adjustments for lifestyle and anthropometric measurements
(BMI and waist circumference) are made. However,
inclusion of fibre and Mg in the model removes the asso-
ciation, suggesting that these factors may account for some
of the effect of whole grains on insulin sensitivity. To date
there have been no large-scale intervention studies to
confirm the beneficial effect of increasing wholegrain food
consumption on insulin sensitivity. In one small interven-
tion study in which eleven overweight and obese hyper-
insulinaemic men followed a strict dietary regimen in
which they ate six to ten portions of whole grains for 6
weeks lower fasting insulin concentrations and improved
insulin sensitivity have been reported (Pereira et al. 2002).
This study, in a high-risk group whose intakes of whole-
grain food exceeded those recommended for the general
population, provides evidence of a beneficial effect but
requires confirmation in the wider population at intakes
that may be achievable in the general population.
Whole grains, inflammation and endothelial function
Inflammation is now recognised as a major contributor
to atherosclerosis and vascular endothelial dysfunction
(Ross, 1999), although the mechanisms involved are not
clear. Pro-inflammatory mediators, including cytokines
such as IL-6, IL-18 and TNFa, are known to be elevated in
overweight and obese individuals (Esposito et al. 2003).
These compounds may affect vascular and endothelial cells
resulting in induction of adhesion molecules, oxidative
stress and reduction in NO production and cell prolifera-
tion, all of which promote atherosclerosis (Haffner, 2003;
Plutzky, 2003). Endothelial dysfunction causes enhanced
and maintained endothelial deactivation, resulting in
elevated plasma concentrations of soluble endothelial
adhesion molecules. Serum concentrations of these
molecules are strongly related to CVD risk in patients
without clinical symptoms of the disease (Brown & Hu,
2001). C-reactive protein (CRP) is an acute-phase protein
secreted by the liver and is also a sensitive marker for
subclinical inflammation and CVD risk (Yudkin et al.
1999; Ridker, 2001). The link between CRP, cytokines and
insulin resistance remains unclear. Liu et al. (2002)
have demonstrated a positive association between plasma
high-sensitivity CRP and dietary glycaemic load in 244
healthy middle-aged women from the Women’s Health
Study, independent of conventional risk factors for
IHD. Their results suggest that perturbations in the pro-
inflammatory process may be a mechanism whereby a high
intake of rapidly-digested and absorbed carbohydrates
(high GI) increases the risk of CVD. In addition, the
authors have noted that the dose–response gradient
between dietary glycaemic load and high-sensitivity CRP
is more apparent for overweight women, thus those who
are more prone to be insulin resistant may be at an even
higher risk of developing this pro-inflammatory state. A
further link with pro-inflammatory changes is shown in the
progression from normal glucose tolerance to impaired
glucose tolerance with accompanying insulin resistance in
which circulating concentrations of plasminogen activator
inhibitor-1 and fibrinogen are progressively increased
(Festa et al. 1999). To date there are no studies in which
markers of inflammatory status or endothelial function
have been compared for different whole-grain intakes.
However, circumstantial evidence of an association can be
drawn from a cross-sectional study of 732 women from the
Nurses’ Health Study cohort by Lopez-Garcia et al. (2004).
In this analysis subjects were divided according to dietary
patterns; the ‘prudent’ pattern included whole grains
whereas the ‘Western’ pattern included refined grains.
It was found that the age-adjusted geometric-mean plasma
concentrations of CRP and E-selectin show decreasing
trends with increasing quintiles of the ‘prudent’ dietary
pattern. In contrast, there are increasing trends with
increasing quintiles of ‘Western’ dietary pattern. Further
analysis of the diets from this cohort using a range of diet
quality scores (Fung et al. 2005) also demonstrates reduced
concentrations of biomarkers of inflammation and endo-
thelial function with higher diet-quality scores for some of
the scoring systems. In a larger study of subjects from
the National Health and Nutrition Examination Survey
1999–2000 Ajani et al. (2004) have shown that dietary
fibre intake is inversely correlated with serum CRP
concentration. Unfortunately, the authors do not report the
sources of dietary fibre, so it is not possible to determine
the contribution of whole grain to fibre intakes. However,
since whole grains make a sizeable contribution to fibre
intake it is likely that those with the higher fibre intakes
will also have higher intakes of whole grains. As a result of
their cross-sectional nature these studies do not establish
causality, but they clearly suggest that improving diet
quality with the inclusion of high-fibre wholegrain food
options is a possible mechanism for reducing these
important markers of CVD risk.
Whole grains and body weight
Several studies have investigated the relationship
between whole-grain consumption and anthropometric
measurements including body weight and BMI, or have
included these variables as part of the analysis of large
population-based studies. A summary of the larger of these
studies is shown in Table 2. The majority of the studies
have relied on self-reported body weights and should
therefore be viewed with some caution, but overall there
is some evidence of a beneficial negative relationship
between whole-grain intake and body weight, albeit
modest. For the Nurses’ Health Study, in which multiple
analyses have been carried out (Liu et al. 1999, 2000a,b),
the data are a little unclear. In one paper (Liu et al. 2000b)
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BMI reportedly ‘did not vary appreciably across quintiles
of intake’ whereas in another paper (Liu et al. 2000a)
‘women with high intake of whole grains . . . weighed
less’. In their 10-year follow-up of the same cohort Liu
et al. (2003) have shown that although BMI increases with
time regardless of levels of grain intake, the increases in
both body weight and BMI are less with increasing
quintiles of whole-grain intake. Interestingly, for the Iowa
Women’s study cross-sectional data appear to suggest no
relationship between whole-grain intake and BMI, albeit
using different methods to categorise subjects (Table 2).
However, in an 8-year follow-up of this cohort self-
reported weight gain has also been shown to be lower for
those in the highest quintile of whole-grain intake com-
pared with those in the lowest quintile of whole-grain
intake at the second time point. Large changes in whole-
grain intake between quintiles of intake over the same
period were reported (- 14.2 g/d for the lowest quintile and
+23.8 g/d for the highest quintile), and it is not known
whether there was tracking of individuals within the
distribution profiles for whole-grain intake. Where similar
longitudinal comparisons were made for the Nurses’
Health cohort (Liu et al. 2003) a highly-significant
(P = 0.02) interaction between whole-grain intake and BMI
at baseline was found. Further confounding of the results
may also have been introduced if the subjects not only
changed their whole-grain intakes but also changed their
lifestyle in line with those known to be associated with
individuals who eat more whole grains (Koh-Banerjee
et al. 2004). Whilst there is limited direct evidence of the
beneficial effect of whole-grain intake on body weight,
there are considerable data on the effects of dietary fibre
(Pereira, 2002). Whether body-weight regulation is an
important mechanism through which whole grains reduce
CVD risk is unclear, and longer-term well-controlled ran-
domised trials investigating this relationship are required.
Summary
Wholegrain foods are considered amongst the healthiest
food choices that are available; however, their consump-
tion remains well below the US recommended level of
three servings per d (US Department of Agriculture, 2005).
These recommended levels have been proposed on the
basis of a growing body of epidemiological data showing
strong evidence for protection against CVD, type 2
diabetes and some cancers. The mechanistic evidence to
support these claims is limited, and therefore there is a
need for well-controlled intervention studies to underpin
the health claims and provide evidence on which to
develop public health strategies to promote whole-grain
consumption. In the UK the Food Standards Agency has
recently commissioned two such intervention studies based
in the University of Newcastle (jointly with the MRC-
HNR, Cambridge, and involving Cereal Partners UK) and
the University of Aberdeen (jointly with the Rowett
Table 2. Effects of whole-grain consumption on body weight and BMI
Study and number of subjects Outcome Reference
Nurses’ Health Study (data from
baseline in 1984) 75 251 women
No change in BMI across quintiles of whole-grain intake
(25 kg/m2 for each quintile)
Liu et al. (1999),
Liu et al. (2000b)
Women with high intakes of whole grain weighed less
(25.0 kg/m2 for lowest quintile of whole-grain intake to
24.4 kg/m2 for the highest quintile, no measure of statistical
analysis included)
Liu et al. (2000a)
Framingham Offspring Study (data from
5th cycle of study, 1991–5) 1338 men,
1603 women
Participants in the highest quintile of whole-grain intake
tended to have a lower BMI than those in the lowest
quintile of whole-grain intake (26.9 kg/m2 for lowest quintile
of whole-grain intake to 26.4 kg/m2 for the highest quintile;
P = 0.06)
McKeown
et al. (2002)
Health Professionals Follow-up study
(data from 1986–1994) 27 802 men
No change in BMI across quintiles of intake at baseline
(25.6 kg/m2 for lowest quintile of whole-grain intake to
24.6 kg/m2 for the highest quintile)
Koh-Banerjee
et al. (2004)
Multivariate-adjusted weight change over 8-year follow-up
was significantly lower across quintiles of whole-grain
intake (+1.87 kg for lowest quintile, + 0.75 kg for highest
quintile; P<0.0001 for trend)
Iowa Women’s Health Study (baseline
data from 1986) 34 492 women
Significant reduction in BMI across quintiles of intake
(27.2 kg/m2 for lowest quintile of whole-grain intake to
26.9 kg/m2 for the highest quintile; P<0.0001 for trend)
Jacobs et al. (1998)
Significant reduction in mean waist : hip ratio across quintiles
of whole-grain intake (0.848 for lowest quintile, 0.832 for
highest quintile; P<0.0001 for trend)
Iowa Women’s Health Study (baseline
data from 1986 for women matched on
eating 6 g total grain fibre intake/8.3 MJ
(2000 kcal) per d) 11 040 women
No difference in BMI between group with whole-grain fibre
contributing 71% of total fibre intake compared with group
with refined grain fibre contributing 77% of total grain fibre
intake (27.0 kg/m2 and 27.2 kg/m2 respectively for
each group)
Jacobs et al. (2000)
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Research Institute and Robert Gordon University) under
the Diet and Cardiovascular Health Research Programme
(N02). These projects are the first large-scale longer-term
(16-week) interventions to be carried out using wholegrain
foods that can readily be incorporated into the diet in order
to meet the target levels suggested in the US Department
of Agriculture (2005) dietary guidelines for Americans.
For both studies outcome variables include comprehensive
measures of CVD risk factors, e.g. blood lipid profiles,
haemostatic and inflammatory markers, and anthropome-
tric measures. These studies, which are expected to report
by the end of 2007, will make an important contribution
to the knowledge of the consequences of increased con-
sumption of whole grains on cardiovascular risk.
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